enabling personalized cancer medicine analysis gene-expression patterns 
therapies patients cancer changed gradually past decade moving away administration broadly acting cytotoxic drugs towards use specific therapies targeted tumour facilitate shift tests need developed identify individuals require therapy likely benefit certain therapies particular tests predict clinical outcome patients basis genes expressed tumours likely increasingly affect patient management heralding new era personalized medicine 
